ResMed Inc.
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionPenserra Capital Management LLC
Latest Disclosed Ownership12 shares
Latest Disclosed Value $ 2
Penserra Capital Management LLC ownership in RMD / ResMed Inc.

On May 11, 2026 - Penserra Capital Management LLC filed a 13F-HR form disclosing ownership of 12 shares of ResMed Inc. (MX:RMD) valued at $2 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 12 shares of ResMed Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F RESMED COM 761152107 12 0 0.00 0 0.0000
2026-02-12 2025-12-31 13F RESMED COM 761152107 12 0 0.00 0 0.0000
2025-11-04 2025-09-30 13F RESMED COM 761152107 12 -780 -98.48 0 0.0000
2025-08-06 2025-06-30 13F RESMED COM 761152107 792 780 6,500.00 0 0.0028
2025-04-29 2025-03-31 13F RESMED COM 761152107 12 -372 -96.88 0 0.0000
2025-02-13 2024-12-31 13F RESMED COM 761152107 384 372 3,100.00 0 0.0016
2024-11-12 2024-09-30 13F RESMED COM 761152107 12 0 0.00 0 0.0000
2024-08-13 2024-06-30 13F RESMED COM 761152107 12 0 0.00 0 0.0000
2024-05-15 2024-03-31 13F RESMED COM 761152107 12 -669 -98.24 0 0.0000
2024-02-14 2023-12-31 13F RESMED COM 761152107 681 -142 -17.25 0 0.0022
2023-11-15 2023-09-30 13F RESMED COM 761152107 823 -131 -13.73 0 0.0025
2023-08-11 2023-06-30 13F RESMED COM 761152107 954 946 11,825.00 0 0.0041
2023-04-24 2023-03-31 13F RESMED COM 761152107 8 0 0.00 0 0.0000
2023-02-13 2022-12-31 13F RESMED COM 761152107 8 8 0 0.0000
2021-02-12 2020-12-31 13F RESMED COM 761152107 0 -468 -100.00 0 -100.00
2020-11-13 2020-09-30 13F RESMED COM 761152107 468 -34,430 -98.66 80 -98.81 0.0030
2020-08-14 2020-06-30 13F RESMED COM 761152107 34,898 34,283 5,574.47 6,700 6,600.00 0.3455
2020-05-14 2020-03-31 13F RESMED COM 761152107 615 -3,629 -85.51 100 -85.55 0.0068
2020-02-14 2019-12-31 13F RESMED COM 761152107 4,244 3,672 641.96 692 798.70 0.0447
2019-11-15 2019-09-30 13F RESMED COM 761152107 572 173 43.36 77 60.42 0.0065
2019-08-13 2019-06-30 13F RESMED COM 761152107 399 33 9.02 48 26.32 0.0037
2019-05-08 2019-03-31 13F RESMED COM 761152107 366 -14,563 -97.55 38 -97.76 0.0030
2019-02-06 2018-12-31 13F RESMED COM 761152107 14,929 14,929 1,699 0.1650
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.